Structures by: Moreira V. M.
Total: 7
3-Oxoandrost-4-en-17β-yl 1H-imidazole-1-carboxylate
C23H30N2O3
Acta Crystallographica Section E (2007) 63, 12 o4824-o4824
a=7.4140(4)Å b=21.2590(10)Å c=13.0036(7)Å
α=90.00° β=92.595(3)° γ=90.00°
3-oxo-5α-androst-17β-yl 2-methyl-1<i>H</i>-imidazole-1-carboxylate
C24H34N2O3
Acta Crystallographica Section C (2009) 65, 3 o88-o91
a=6.5828(2)Å b=12.3368(5)Å c=26.4702(10)Å
α=90.00° β=90.00° γ=90.00°
3-Oxoandrosta-4,6-dien-17β-yl 2-methyl-1<i>H</i>-imidazole-1-carboxylate
C24H30N2O3
Acta Crystallographica Section C (2009) 65, 3 o88-o91
a=24.5935(5)Å b=7.03510(10)Å c=24.9875(4)Å
α=90.00° β=105.1160(11)° γ=90.00°
17-(1<i>H</i>-indazol-1-yl)androsta-5,16-dien-3β-ol
C26H32N2O
Acta Crystallographica Section C (2008) 64, 4 o217-o219
a=6.04450(10)Å b=12.1149(2)Å c=28.9321(4)Å
α=90.00° β=90.00° γ=90.00°
17-(2<i>H</i>-indazol-2-yl)androsta-5,16-dien-3β-ol
C26H32N2O
Acta Crystallographica Section C (2008) 64, 4 o217-o219
a=5.9234(2)Å b=13.0938(4)Å c=13.6623(4)Å
α=90.00° β=91.5347(16)° γ=90.00°
17-chloro-16-formylandrosta-5,16-dien-3β-yl acetate
C22H29ClO3
Acta Crystallographica Section C (2008) 64, 9 o529-o531
a=6.0689(2)Å b=13.2879(4)Å c=24.7664(8)Å
α=90.00° β=90.00° γ=90.00°
17-chloro-androsta-5,16-dien-3β-yl acetate
C21H29ClO2
Acta Crystallographica Section C (2008) 64, 9 o529-o531
a=6.0271(2)Å b=15.4064(6)Å c=20.6081(9)Å
α=90.00° β=90.00° γ=90.00°